Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11326
PUT
Bakkt Inc
BKKT
$349M
| $132K | ﹤0.01% |
15,200
-36,500
| -71% | -$623K |
|
11327
CALL
A2Z Smart Technologies
AZ
$281M
| $131K | ﹤0.01% |
+18,600
| New | +$129K |
|
|
WOW
11328
CALL
DELISTED
WideOpenWest
WOW
| $131K | ﹤0.01% |
26,500
-88,600
| -77% | -$407K |
|
11329
AlTi Global
ALTI
$466M
| $131K | ﹤0.01% |
43,039
+28,203
| +190% | +$101K |
|
11330
Gyre Therapeutics
GYRE
$696M
| $131K | ﹤0.01% |
+16,931
| New | +$186K |
|
11331
CALL
Greystone Housing Impact Investors LP
GHI
$151M
| $131K | ﹤0.01% |
+10,600
| New | +$131K |
|
11332
Contango Silver & Gold Inc
CTGO
$645M
| $131K | ﹤0.01% |
+12,791
| New | +$131K |
|
11333
PUT
Prairie Operating Co
PROP
$60.5M
| $131K | ﹤0.01% |
+24,400
| New | +$178K |
|
11334
iBio
IBIO
$67.6M
| $130K | ﹤0.01% |
+32,413
| New | +$126K |
|
11335
Pliant Therapeutics
PLRX
$69.4M
| $130K | ﹤0.01% |
96,467
+27,893
| +41% | +$169K |
|
11336
Sight Sciences
SGHT
$465M
| $130K | ﹤0.01% |
54,252
+27,017
| +99% | +$76.1K |
|
|
UPB
11337
Upstream Bio Inc
UPB
$370M
| $130K | ﹤0.01% |
+21,264
| New | +$203K |
|
11338
CALL
BRC Inc
BRCC
$122M
| $130K | ﹤0.01% |
6,220
+690
| +12% | +$17.6K |
|
|
VFL
11339
DELISTED
abrdn National Municipal Income Fund
VFL
| $130K | ﹤0.01% |
12,789
-4,031
| -24% | -$42K |
|
|
KWY
11340
Kingsway Corp
KWY
$299M
| $130K | ﹤0.01% |
+16,355
| New | +$129K |
|
|
OLO
11341
CALL
DELISTED
Olo Inc
OLO
| $129K | ﹤0.01% |
21,400
-12,800
| -37% | -$89.4K |
|
11342
CALL
Arcos Dorados Holdings
ARCO
$1.69B
| $129K | ﹤0.01% |
16,000
-13,200
| -45% | -$104K |
|
11343
CALL
Red Robin
RRGB
$178M
| $129K | ﹤0.01% |
36,200
-30,500
| -46% | -$156K |
|
|
BWG
11344
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$128M
| $129K | ﹤0.01% |
15,410
-1,537
| -9% | -$12.8K |
|
11345
PUT
The Joint Corp
JYNT
$119M
| $129K | ﹤0.01% |
+10,300
| New | +$116K |
|
|
FNUC
11346
Frontier Nuclear and Minerals Inc
FNUC
$54.2M
| $129K | ﹤0.01% |
19,211
+5,874
| +44% | +$51.5K |
|
|
BACQU
11347
DELISTED
Inflection Point Acquisition Corp IV Unit
BACQU
| $128K | ﹤0.01% |
+12,632
| New | +$128K |
|
11348
CALL
Aquestive Therapeutics
AQST
$633M
| $128K | ﹤0.01% |
44,200
-43,500
| -50% | -$132K |
|
11349
PUT
Wabash National
WNC
$537M
| $128K | ﹤0.01% |
11,600
-4,300
| -27% | -$57.8K |
|
11350
PUT
Amylyx Pharmaceuticals
AMLX
$3.87B
| $128K | ﹤0.01% |
36,200
-193,500
| -84% | -$689K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.